0 items USD 0.00Search
Your search for "delveinsight progesterone receptor agonists pipeline insights 2016" gave back 83 results.
Market Reserach Reports, Inc is running a promotion until the end of April for a bundle of four antibody-related reports with a 50% discount on the...
Catalog:
La Merie Publishing
March 2014
Price: USD 4,766.00
Anti-Her2 Antibody-Drug Conjugates in: September 2016 R&D and Business Tracker for Antibody-Drug Conjugates This pdf report contains information...
Catalog:
La Merie Publishing
October 2016
Price: USD 225.00
CD33-Targeted Immunotherapeutics in: September 2016 R&D and Business Tracker for TCR & CAR T-Cells and NK Cells This pdf report contains...
Catalog:
La Merie Publishing
October 2016
Price: USD 225.00
CD123-Targeted Immunotherapeutics in: September 2016 R&D and Business Tracker for Bispecific Antibodies This pdf report contains information...
Catalog:
La Merie Publishing
October 2016
Price: USD 225.00
This pdf report contains information about Antibody-Drug Conjugates (ADCs) released during the month of October 2016. Featured presentations of...
Catalog:
La Merie Publishing
November 2016
Price: USD 225.00
Substance Abuse Deterrents and Treatments - An Assessment of the Technological, Competitive and R&D Landscape Summary GBI Research's latest...
CBR Pharma Insights
March 2016
Price: USD 2,995.00
This report describes and evaluates the competitive landscape of CD22-targeted immunotherapeutics based on different treatment modalities. In B-cell...
Catalog:
La Merie Publishing
November 2016
Price: USD 784.00
This report evaluates G-protein–coupled receptor family C group 5 member D (GPRC5D) from an industry perspective for its suitability as a tumor-...
Catalog:
La Merie Publishing
July 2022
Price: USD 670.00
RNA-Targeted Novel Drug Modalities Based on RNA Editing, Epitranscriptomics, Direct RNA Targeting, Splicing Modulation, Translation Regulation,...
Catalog:
La Merie Publishing
November 2022
Price: USD 2,500.00
Pharmaceutical Lifecycle Management Strategies in 2017 Summary GBI Research’s latest report, "Pharmaceutical Lifecycle Management Strategies in...
CBR Pharma Insights
April 2017
Price: USD 2,995.00
Opioids Overview to 2021 An Assessment of Pain Management and Dependence report discusses the use of opioids as potent analgesics for the treatment...
Catalog:
CBR Pharma Insights
August 2015
Price: USD 2,995.00
There has been incessant rise in prevalence of atrial fibrillation and other heart-related medical conditions such as valvular heart diseases and...
Catalog:
Rockville Research
February 2018
Price: USD 1,050.00
Gene Therapies: A Growing Pipeline and Approval of CAR-T Cell Therapies Reflect Increasing Commercial Appeal, Despite Difficulties Faced by products...
Catalog:
CBR Pharma Insights
January 2018
Price: USD 2,995.00
Gene Therapies: A Diverse Range of Technologies with a Promising Long-Term Outlook Summary GBI Research’s latest report, "Gene Therapies: A...
Catalog:
CBR Pharma Insights
September 2015
Price: USD 2,995.00
Biosimilars are copied versions of biologics that offer a 20-50% reduction in cost compared with innovative biologic products. Biosimilars are...
Catalog:
CBR Pharma Insights
June 2015
Price: USD 2,995.00
